NR1H4 and obesity disorder: Notably, studies have demonstrated that hepatic FXR signaling and intestinal FXR signaling seem to have diametrically opposite effects—activating hepatic FXR prevents steatosis46, while intestine-specific Fxr−/− mice exhibit improved obesity-related metabolic dysfunction47.